8-K
filed May 15, 2026, 9:28 AM ET
ticker FORA
CIK 0001829280
M&A
confidence high
sentiment neutral
materiality 1.00
Forian Inc. (FORA): M&A transaction — Forian completes acquisition by 2025 Acquisition Company at $2.17/share; to delist from Nasdaq
Forian Inc.
- 6,444,415 shares validly tendered; together with Buyer Parties' 21,991,929 shares, ~91% of outstanding shares.
- Shareholders (other than Buyer Parties) received $2.17 per share in cash; no interest, less withholding.
- Following tender acceptance, Merger Sub merged into Forian; company becomes wholly owned subsidiary of Parent.
- All directors except Max Wygod resigned; Max Wygod remains sole director of surviving corporation.
- Forian requested Nasdaq delisting and intends to file Form 15 to suspend SEC reporting obligations.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Ian G. Banwell resigned as director at Forian Inc..
- Action
- resigned
- Role
- director
Exact text from the filing
At the Effective Time, Mark J. Adler, M.D., Ian G. Banwell, Adam Dublin, Jennifer Hajj, Shahir Kassam-Adams, Alyssa Varadhan and Kristiina Vuori, M.D., Ph.D. each resigned from the board of directors of the Company (the “ Board ”) and from all committees of the Board on which they served, and Max Wygod remained as the sole director of the Surviving Corporation.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Kristiina Vuori, M.D., Ph.D. resigned as director at Forian Inc..
- Action
- resigned
- Role
- director
Exact text from the filing
At the Effective Time, Mark J. Adler, M.D., Ian G. Banwell, Adam Dublin, Jennifer Hajj, Shahir Kassam-Adams, Alyssa Varadhan and Kristiina Vuori, M.D., Ph.D. each resigned from the board of directors of the Company (the “ Board ”) and from all committees of the Board on which they served, and Max Wygod remained as the sole director of the Surviving Corporation.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Mark J. Adler, M.D. resigned as director at Forian Inc..
- Action
- resigned
- Role
- director
Exact text from the filing
At the Effective Time, Mark J. Adler, M.D., Ian G. Banwell, Adam Dublin, Jennifer Hajj, Shahir Kassam-Adams, Alyssa Varadhan and Kristiina Vuori, M.D., Ph.D. each resigned from the board of directors of the Company (the “ Board ”) and from all committees of the Board on which they served, and Max Wygod remained as the sole director of the Surviving Corporation.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Jennifer Hajj resigned as director at Forian Inc..
- Action
- resigned
- Role
- director
Exact text from the filing
At the Effective Time, Mark J. Adler, M.D., Ian G. Banwell, Adam Dublin, Jennifer Hajj, Shahir Kassam-Adams, Alyssa Varadhan and Kristiina Vuori, M.D., Ph.D. each resigned from the board of directors of the Company (the “ Board ”) and from all committees of the Board on which they served, and Max Wygod remained as the sole director of the Surviving Corporation.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Adam Dublin resigned as director at Forian Inc..
- Action
- resigned
- Role
- director
Exact text from the filing
At the Effective Time, Mark J. Adler, M.D., Ian G. Banwell, Adam Dublin, Jennifer Hajj, Shahir Kassam-Adams, Alyssa Varadhan and Kristiina Vuori, M.D., Ph.D. each resigned from the board of directors of the Company (the “ Board ”) and from all committees of the Board on which they served, and Max Wygod remained as the sole director of the Surviving Corporation.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Alyssa Varadhan resigned as director at Forian Inc..
- Action
- resigned
- Role
- director
Exact text from the filing
At the Effective Time, Mark J. Adler, M.D., Ian G. Banwell, Adam Dublin, Jennifer Hajj, Shahir Kassam-Adams, Alyssa Varadhan and Kristiina Vuori, M.D., Ph.D. each resigned from the board of directors of the Company (the “ Board ”) and from all committees of the Board on which they served, and Max Wygod remained as the sole director of the Surviving Corporation.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Shahir Kassam-Adams resigned as director at Forian Inc..
- Action
- resigned
- Role
- director
Exact text from the filing
At the Effective Time, Mark J. Adler, M.D., Ian G. Banwell, Adam Dublin, Jennifer Hajj, Shahir Kassam-Adams, Alyssa Varadhan and Kristiina Vuori, M.D., Ph.D. each resigned from the board of directors of the Company (the “ Board ”) and from all committees of the Board on which they served, and Max Wygod remained as the sole director of the Surviving Corporation.
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
Forian Inc.: Bylaws amended and restated in their entirety (effective 2026-05-15).
- Change
- bylaw amendment
- Effective
- 2026-05-15
Exact text from the filing
on May 15, 2026, the Company’s articles of incorporation and bylaws were each amended and restated in their entirety
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
Forian Inc.: Articles of incorporation amended and restated in their entirety (effective 2026-05-15).
- Change
- charter amendment
- Effective
- 2026-05-15
Exact text from the filing
on May 15, 2026, the Company’s articles of incorporation and bylaws were each amended and restated in their entirety
View on SEC.gov
M&A Transactions
SEC 8-K Item 2.01/5.01
confidence 0.9
Forian Inc. underwent a change of control involving 2025 Acquisition Company, LLC for $2.17 per share in cash (closed 2026-05-15).
- Action
- change of control
- Counterparty
- 2025 Acquisition Company, LLC
- Consideration
- $2.17 per share in cash
- Closing
- 2026-05-15
Exact text from the filing
the “ Offer ”) to acquire any and all of the issued and outstanding shares of common stock, par value $0.0001 per share of the Company (the “ Shares ”), at a purchase price of $2.17 per Share, in cash, without interest thereon and less any applicable tax withholding (the “ Offer Price ”). The Offer and related withdrawal rights expired as scheduled one
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.